PRGO


Perrigo Completes Sale of Generic Rx Pharmaceuticals Business $1.55B

Consumer self-care products company Perrigo Company plc (PRGO) recently announced that it has completed the sale of its Generic Rx Pharmaceuticals business. The …

Perrigo Divests Mexico And Brazil OTC Units

Over-the-counter (OTC) health and wellness solutions provider Perrigo Company (PRGO) has agreed to sell its OTC units in Mexico and Brazil to Advent …

Acquisition Limbo Begins for Three Major Generic Drugmakers: TEVA, MYL, PRGO

Teva Pharmaceuticals Industries Ltd (ADR) (NYSE:TEVA) has made an official and unsolicited bid for rival generic drugmaker Mylan NV (NASDAQ:MYL), offering $82/share in a combination …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts